Navigation Links
China Medical Technologies Adjusts Conversion Rate of Convertible Notes
Date:7/25/2008

BEIJING, July 25 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy systems, today announced adjustment to conversion rate for the Company's US$150 million outstanding 3.5% Convertible Senior Subordinated Notes due November 2011 (the ''Convertible Notes'').

Conversion rate of the Convertible Notes is adjusted from 31.3953 American Depositary Shares (''ADSs'') to 31.7378 ADSs for each US$1,000 original principal amount of the Convertible Notes with reference to the closing market price of the Company's ADSs on July 24, 2008. The resulting conversion price for the Convertible Notes is reduced from US$31.85 to US$31.51. The adjustment is effective immediately prior to the opening of business on July 25, 2008, Eastern Time. The adjustment is required, in accordance with the terms of the indenture governing the Convertible Notes, as a result of the Company's declaration of cash dividend of US$0.05 per share, equivalent to US$0.50 per ADS. Assuming full conversion of the Convertible Notes, additional 513,750 ordinary shares, equivalent to 51,375 ADSs will be issued by the Company as a result of the adjustment to conversion rate.

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostics products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and system using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For more information, please visit http://www.chinameditech.com .

For more information, please contact:

Winnie Yam

Tel: +86-10-6530-8833

Email: IR@chinameditech.com


'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Files Application for Nasdaq Listing
2. China Biologic Products Honored with the Advanced Technology Certification for Foreign-Funded Enterprises
3. China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008
4. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
5. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
6. China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province
7. China Agritech to Export Products to Egypt
8. China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 2008
9. China Pharma Holdings, Inc. to Present at Collins Stewart Fourth Annual Growth Conference in New York on July 8, 2008 at 2:00 p.m. EDT
10. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
11. China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County, Guangxi Province
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Brain Sentinel, Inc. has received ... SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting System. The adjunctive seizure ... periods of rest. A lightweight, non-invasive monitor is placed on the belly of ...
(Date:2/23/2017)... ... February 23, 2017 , ... David Nolte, PhD accepted Purdue ... Purdue Research Park of West Lafayette, Indiana. , The top commercialization ... to, and success with, commercializing discoveries from Purdue research. “This award is truly ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, Inc , ... Compass Research . GGI's mission is to advance global health and highlight the ... need in honor of each clinical trial volunteer. The vision of GGI is to ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... research tools, announced the acquisition of GenWay Biotech ... a comprehensive service and product offering for both ... acquisition will facilitate growth and enhance capabilities for ... antibodies, and ELISA assays will nicely complement ASB,s ...
Breaking Biology Technology:
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, ... a new report, Sensors for Robotics: Technologies, Markets and Forecasts ... ... Revenues ... "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force ...
Breaking Biology News(10 mins):